GLP-1 Telehealth Provider Reviews
Independent reviews of every major GLP-1 telehealth provider, plus a side-by-side comparison table. We cover cash-pay pricing, prescribing protocols, monitoring quality, and what patients actually experience.
Compare all providers
Which Telehealth Companies Sell GLP-1 Drugs in 2026? A Sourced Provider Map
A sourced map of how US patients actually get GLP-1s in May 2026: manufacturer-direct (NovoCare, LillyDirect), insurance-first telehealth (Calibrate, WeightWatchers Clinic, Form Health), cash-pay brand-only resellers (Ro, LifeMD), compounded-GLP-1 sites under §503A(b)(1)(D), and primary-care models (Knownwell). What the business model behind each channel does to your monthly bill.
Best Cash-Pay GLP-1 Telehealth Platforms in 2026
No insurance for GLP-1s? Here are the lowest-cost legal options for compounded semaglutide and tirzepatide — and when the branded direct-pay programmes are worth the extra cost.
Best Insurance-Friendly GLP-1 Telehealth Platforms in 2026
Commercial insurance can cover Wegovy or Zepbound — but only if someone does the prior-authorisation work. These platforms are built to get you through that process.
Provider reviews
Hims Weight Loss in May 2026: Pricing, Sign-Up Process, and the Compounding Question
An editorial review of Hims's GLP-1 weight-loss programme as of May 2026 — built from SEC filings, FDA warning letters, court records, and the Novo Nordisk settlement. We have not yet completed a hands-on sign-up; an update follows when we do.
Ro Body Review: Branded Wegovy and Ozempic via NovoCare (May 2026)
Ro Body is a branded-only GLP-1 telehealth platform and active NovoCare partner. Drug costs start at $199/mo for Wegovy — but that's before Ro's $149/mo membership fee.
Henry Meds Review: GLP-1 Compounding Specialist, May 2026
Henry Meds is one of the few telehealth providers still operating a compounded GLP-1 program in May 2026. This review covers their current compounding-status reality, pricing, sign-up process, formulary, support quality, and cancellation — built from public sources and test account data.
Mochi Health Review: GLP-1 Telehealth with Insurance Support (May 2026)
Mochi Health sits between the cash-pay compounding specialists and the insurance-primary primary-care path. They navigate insurance for the GLP-1 prescription, offer compounded options for cash-pay patients, and have a clinician-relationship model that differs from most asynchronous competitors. Here is what the experience actually looks like.
Found Health Review 2026: Wide Formulary, Insurance Navigation, Hidden Fees
Found offers the widest GLP-1 formulary in telehealth — including Foundayo (orforglipron) from April 2026 — and genuine insurance PA support. The main friction is a $99 cancellation fee and a dual-billing structure that consistently surprises patients.
Noom Med Review 2026: Strong Behavioral Model, Opaque Quarterly Billing
Noom Med combines GLP-1 prescriptions with CBT-based behavioral coaching in a mandatory app. The behavioral layer is real and distinguishes it from medication-only providers. The pricing structure — $69 advertised, $837 billed quarterly — is not.
Calibrate Review: The Insurance-First GLP-1 Program (May 2026)
Calibrate built its entire model around one bet: that commercial insurance will cover your GLP-1 if someone fights hard enough for it. That bet has paid off for tens of thousands of members — and created serious problems for thousands of others. Here is what the program actually looks like in 2026.
Form Health Review: ABOM-Certified Obesity Medicine Telehealth (May 2026)
Form Health is one of the most clinically rigorous GLP-1 telehealth platforms in the US. Its care team is led by an American Board of Obesity Medicine certified physician — the highest specialty credential in obesity medicine — and each patient gets a Registered Dietitian alongside their prescriber. The trade-off is that Form Health is built around insurance coverage; cash-pay patients pay $299 per month for the program before medication costs.
Eden Weight Loss Review: Compounded GLP-1 Specialist (May 2026)
Eden offers compounded semaglutide from $129 (first month) under a 503A patient-specific framing. Cash-pay only. No FDA warning letter as of May 2026. Full pricing, Reddit patient signal, and continuity risk explained.
Plushcare Weight Loss Review: Insurance-First GLP-1 Prescriptions (May 2026)
Plushcare prescribes branded GLP-1s through a $19.99/mo primary-care telehealth membership — the right fit if your insurance covers Wegovy, the wrong one if you're paying cash.
Fella Health Review: Men’s GLP-1 Platform, May 2026
Fella Health is the largest men’s-only GLP-1 telehealth platform in the US. This review covers their current compounding status, a pending Novo Nordisk trademark lawsuit, current pricing, sign-up process, formulary, coaching model, and how they compare to Henry Meds.
LifeMD Weight Loss Review: Membership Model, NovoCare Pricing, and the Compounding Pivot (May 2026)
LifeMD is a NASDAQ-listed telehealth platform with a two-tier pricing model — a $149/mo program fee on top of drug costs. This review maps the full all-in cost, the NovoCare integration, and who the membership structure actually suits.
WeightWatchers Clinic Review: GLP-1 Prescriptions, Pricing, and the Post-Bankruptcy Reality (May 2026)
WeightWatchers Clinic is the GLP-1 telehealth arm of WW — built on the 2023 Sequence acquisition, survived a 42-day Chapter 11, and now operates as an active NovoCare partner. Membership is $74/month. The drug is a separate bill.
Provider comparisons
Hims vs Ro for GLP-1 Weight Loss: Side-by-Side Comparison (May 2026)
Both Hims and Ro are now branded-only GLP-1 platforms. Here is what actually differs in May 2026 — pricing, drug options, support, and who should choose which.
Mochi Health vs PlushCare: Which GLP-1 Platform Is Right for You?
A head-to-head comparison of Mochi Health and PlushCare for GLP-1 weight loss. True monthly costs, compounding access, PA support, and the risk factors neither homepage advertises.
Henry Meds vs Mochi Health (2026): The Real Cost Difference at Maintenance Dose
Henry Meds looks cheaper at $297/mo until you hit maintenance dose. Mochi's flat-rate model and insurance path make it the better long-term play for most tirzepatide users. Here is the full comparison.